Basic Information
ID: ALA3541569
Type: ADME
Description: Drug metabolism in human liver S9 fraction treated with 20 uM [14C]boceprevir assessed as quercetin-mediated inhibition of metabolite formation by LC-MS/MS/FSA method
Organism: Homo sapiens
Tissue: Liver
Subcellular Fraction: Liver S9 fraction
Activity Charts
Bioactivity
Activity Types for Assay ALA3541569
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 521.70 | 1.50 | 1.50 |